Reuters logo
BRIEF-Delcath announces patient treatment in intrahepatic Cholangiocarcinoma study
January 12, 2017 / 2:44 PM / a year ago

BRIEF-Delcath announces patient treatment in intrahepatic Cholangiocarcinoma study

Jan 12 (Reuters) - Delcath Systems Inc :

* Delcath Systems Inc - patient treatment, data collection for intrahepatic cholangiocarcinoma (ICC) cohort of European Phase 2 HCC/ICC study is ongoing

* Delcath Systems Inc - will announce interim results for cohort once data are fully mature

* Delcath Systems Inc - “original goal to obtain an efficacy signal for Phase 2 ICC cohort has been satisfied”

* Delcath Systems Inc - ”PHP() therapy does, indeed, “demonstrate an efficacy signal in ICC and is worthy of full clinical investigation.” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below